ICU sedation, delirium & recovery
Long-term prevalence of PTSD symptom in family members of severe COVID-19 patients: a serial follow-up study extending to 18 months after intensive care unit (ICU) discharge
Study context
- Population
- Family members of severe COVID-19 ICU patients, tertiary university hospital in Tokyo, July 2020 to June 202268 participated
- Participants
- 97 members
- Outcome
- Family member PTSD symptoms (Impact of Events Scale-Revised score > 24)
- Follow-up
- 6, 12 and 18 months after ICU discharge
Methodological detailssingle-centre, serial follow-up
- Single-centre
- Serial follow-up
Main finding
As reported in the abstract
PTSD symptoms (prevalence)
At least one PTSD-related symptom, persisting over 18 months post-discharge
26%
PTSD symptoms at 6 months
16%
PTSD symptoms at 12 months
23%
PTSD symptoms at 18 months
25%
Observational data: associations, not effects.
Secondary outcomes
Delayed-onset PTSD symptoms
- Subgroup with delayed-onset PTSD symptoms
- 15%
Health-related quality of life (HRQOL)
- Lower HRQOL in family members with PTSD-related symptoms, especially mental and social components
Original publication
Long-term prevalence of PTSD symptom in family members of severe COVID-19 patients: a serial follow-up study extending to 18 months after ICU discharge. J Intensive Care. Published 18 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →